After 2 years of the COVID-19 pandemic, the Annual Meeting of the American Society of Clinical Oncology(ASCO), was held in Chicago, USA, and virtually from 3rd–7th June, 2022. As always, the very much-anticipated event brought leading experts from across the globe together to learn and discuss the groundbreaking updates and scientific advancements in multiple solid tumor entities. This report provides a comprehensive overview of novel agents or combinations in recurrent or metastatic nasopharyngeal cancer as well as innovative combinations inesophageal squamous cell carcinoma. Since the prevalence of gastric and gastrointestinal junction cancer increased in the last years, we are also dedicating a chapter to updated analyses and novel therapeutic options including CAR T-cell therapy. Moreover, future treatment strategies in advanced or metastatic colorectal cancer as well as up-to-date clinical insights in advanced unresectable or metastatic hepatocellular carcinoma are depicted.

As an additional feature, you willfind expert video interviews with Kohei Shitara, Anna Spreafico, Ian Chau and Julien Edeline on various conference highlights on our website.

Download the report, or visit memo inOncology

Access an article directly (English):

Preface

Novel agents or combinations in recurrent or metastatic nasopharyngeal cancer

Innovative combinations in esophageal squamous cell carcinoma

An update and future directions in advanced gastric or gastrointestinal junction cancer (G/GEJC)

New therapeutic options being currently investigated in advanced or metastatic colorectal cancer

New clinical insights in hepatocellular carcinoma

DOWNLOAD (ENGLISH)